NCT05183854 2026-02-17
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
University of Utah
Phase 2 Recruiting
Clinical Trials
3 trialsLeukemia, Lymphocytic, Chronic, B-Cell × 23-valent pneumococcal capsular polysaccharide vaccine × 1 year × Clear all
NCT05417165 2026-01-07
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT01351896 2025-11-20
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting